Rights Issue Information Booklet
Filed with ASX · · 40 pages · English
If you are an Eligible Shareholder, this document is important and requires your immediate attention. It should be read in its entirety. This document is not a prospectus under the Corporations Act 2001 (Cth) and has not been lodged with the Australian Securities & Investments Commission. If you have any questions, you should contact your stockbroker, solicitor, accountant or other professional ad
In the deck
Earlier from Invion
- Appendix 4C - December 2017 Quarter
- Appointment of Non Executive Director and Chairman
- AGM - Withdrawal of Resolution prior to Meeting
- AGM Notice of Meeting And Proxy Form
- Appendix 4C - cashflow statement for the September quarter
Later from Invion
- Appendix 4D and Financial Report for half year to 31 Dec 17
- Completion iof Rights Issue
- Invion alliance with Hudson Institute of Medical Research
- Appendix 4C - March 2018 quarter
- Photosoft efficiently destroys ovarian cancer cells in vitro
Follow Invion into a list and get an email when it puts out news.
Follow Invion